公司资料
Curis Inc 股价、新闻与催化剂
- 股票代码:
- CRIS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.80 USD (0.00%)
收盘价
最后更新: 2026年8月17日
19.6M USD
市值
股价为何变动
As of Aug 17, 2026, CRIS was little changed and closed at $1.80. No new same-company headline was identified in the current news window.
公司概览
业务概览
Curis is a biotechnology company focused on oncology and immune-modulating therapies. Its story has been shaped by a small pipeline and repeated efforts to create durable value.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Curis sits in specialty biotechnology.
商业模式特征
The company depends on clinical data, strategic focus, and the ability to build a more durable oncology and immunology story.
生物医药行业定位
Curis is a small-cap catalyst name whose valuation depends on development progress and strategic clarity.
未来催化剂
- Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value. The company needs a cleaner development path to matter again.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。